Cancer Detection Biz To Go Public Via $694M SPAC Merger
By Jade Martinez-Pogue · September 25, 2024, 4:42 PM EDT
Special purpose acquisition company Breeze Holdings Acquisition Corp. on Wednesday announced that it has agreed to merge with and take public clinical-stage biopharmaceutical company YD Biopharma Ltd. in a deal that...
To view the full article, register now.